GLB 2009
Alternative Names: GLB-2009Latest Information Update: 02 Jun 2021
At a glance
- Originator GeneLeap Biotech
- Class Gene therapies; Oligonucleotides
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Unspecified
Most Recent Events
- 25 May 2021 Early research in Unspecified in USA (unspecified route) (GeneLeap Biotech pipeline, May 2021)